Sunday, November 13, 2022
- 9:00AM-10:30AM
-
Abstract Number: 0635
Blood RNA-sequencing Reveals Complex Immune Dysregulation in ANA-positive Individuals with Distinct Profiles Preceding Progression to SLE versus Stable Autoimmunity
SLE – Etiology and Pathogenesis Poster- 9:00AM-10:30AM
-
Abstract Number: 0836
Bone Turnover and Physical Activity Before and After Anterior Cruciate Ligament Reconstruction
Orthopedics, Low Back Pain, and Rehabilitation Poster- 9:00AM-10:30AM
-
Abstract Number: 0783
Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases
Infection-related Rheumatic Disease Poster- 9:00AM-10:30AM
-
Abstract Number: 0784
Breakthrough SARS-CoV-2 Infections in Immune Mediated Disease Patients Undergoing B Cell Depleting Therapy: A Retrospective Cohort Analysis
Infection-related Rheumatic Disease Poster- 9:00AM-10:30AM
-
Abstract Number: 0607
Cadherin 6 Regulates Rheumatoid Arthritis Fibroblasts-Like Synoviocyte Aggressiveness
RA – Etiology and Pathogenesis Poster- 9:00AM-10:30AM
-
Abstract Number: 0767
Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO) – A Retrospective Chart Review Study of Adults with Inflammatory Arthritis Associated with Cancer Immunotherapies
Immunological Complications of Medical Therapy Poster- 9:00AM-10:30AM
-
Abstract Number: 0813
Canakinumab in Patients with Tumor Necrosis Factor Receptor-associated Periodic Syndrome (TRAPS) – Long-term Efficacy and Safety Data from a RELIANCE Registry Interim Analysis
Miscellaneous Rheumatic and Inflammatory Diseases Poster II- 9:00AM-10:30AM
-
Abstract Number: 1066
Capillaroscopic Findings in Autoimmune Connective Tissue Diseases: Results from 20 Years of Experience in a Training Referral Center
Systemic Sclerosis and Related Disorders – Clinical Poster I- 9:00AM-10:30AM
-
Abstract Number: 0722
Cardiovascular and Oncologic Outocomes of Anti-TNF Alfa and JAK Inhibitors in Patients with Rheumatoid and Psoriatic Arthritis. Real World Data and Insights of BIOBADASAR 3.0 Registry
Epidemiology and Public Health Poster I- 9:00AM-10:30AM
-
Abstract Number: 0888
Cardiovascular and Thromboembolic Events in Rheumatoid Arthritis Patients Before and After Initiation of a First Advanced Therapy. Data from the University of Sherbrooke Registry of Advanced Therapies (USRAT)
RA – Diagnosis, Manifestations, and Outcomes Poster II- 9:00AM-10:30AM
-
Abstract Number: 1016
Cardiovascular Disease Proteome Profile Is Related to an Abnormal Methylome Pattern in Spondyloarthritis: Potential Biomarkers of Subclinical Atherosclerosis
Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes Poster II- 9:00AM-10:30AM
-
Abstract Number: 0766
CCP+ Immune Checkpoint Inhibitor Arthritis Patients Have Less ACPA Epitope Expansion Than CCP+ Rheumatoid Arthritis Patients
Immunological Complications of Medical Therapy Poster- 9:00AM-10:30AM
-
Abstract Number: 0624
CD20+ T Cells in the Synovial Fluid of Patients with Rheumatoid Arthritis Suggest a Role for Trogocytosis in Disease Pathogenesis and Activity
RA – Etiology and Pathogenesis Poster- 9:00AM-10:30AM
-
Abstract Number: 0873
Celiac-Associated Arthritis: Clinical Features, Treatment, and Outcomes